J&R Research and the FTC agreed that J&R would restrict the health claims advertised about J&R's products in exchange for the FTC withdrawing it's complaint against the company. J&R made a variety of claims that its products cured or treated a significant number of health problems, such as diabetes, arthritis, lupus, stroke, high blood pressure, and others. The FTC claimed that there existed no competent scientific evidence that supported the company's effectiveness claims. In settling the dispute, J&R agreed to no longer advertise certain enumerated health benefits without corresponding scientific support. Additionally, the company agreed to cease using customer testimonials that are not typical or ordinary without disclosing the generally expected results or the limited applicability of the endorser’s testimony.

The full case and case summary are also available online at: http://www.mlmlegal.com/legal-cases/IntheMatterofJ&RResearchCorp.php